JAMA oncology, 2374-2437


  1. 2020
  2. 2019
  3. DCOG LATER Study Grp, Kok, J. L., Teepen, J. C., van der Pal, H. J., van Leeuwen, F. E., Tissing, W. J. E., ... Ronckers, C. M. (2019). Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer. JAMA oncology, 5(5), 671-680. https://doi.org/10.1001/jamaoncol.2018.6862
  4. 2018
  5. Targeted Alpha Therapy Working Grp, Parker, C., Lewington, V., Shore, N., Kratochwil, C., Levy, M., ... Saad, F. (2018). Targeted Alpha Therapy, an Emerging Class of Cancer Agents A Review. JAMA Oncol, 4(12), 1765-1772. https://doi.org/10.1001/jamaoncol.2018.4044
  6. Cowan, A. J., Allen, C., Barac, A., Basaleem, H., Bensenor, I., Curado, M. P., ... Fitzmaurice, C. (2018). Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016. JAMA oncology, 4(9), 1221-1227. https://doi.org/10.1001/jamaoncol.2018.2128
  7. 2016

ID: 37132924